ライフサイエンスコーパス: to demonstrate

1 utside of the lung has been more challenging to demonstrate.

2 dolescent symptom trajectories has been hard to demonstrate.

3 ions in all-cause mortality (ACM) are harder to demonstrate.

4 s (CoDa) and classical statistical analyses, to demonstrate (1) how aging affects beer and (2) how th

5 nt, aspects of memory that have been thought to demonstrate a fixed working memory capacity of around

6 This capability is then exploited to demonstrate a form of single-pixel imaging, where a s

7 We were able to demonstrate a high effectiveness of the AMPLATZER Car

8 oefficient and small mode volume, enabled us to demonstrate a Kerr frequency comb threshold of only ~

9 To demonstrate a model for characterizing the potential

10 PD, to demonstrate the validity of a PRS and to demonstrate a novel gene-environment interaction, whe

11 administration with economic demand analysis to demonstrate a novel mechanism by which cocaine potenc

12 ply state-of-the-art microfluidic technology to demonstrate a one-step immunoassay for the detection

13 developed and applied to a set of four PAHs to demonstrate a possible solution to this challenge.

14 Auger electron spectroscopy is applied to demonstrate a postdeposition purification process in

15 ngled state on an OLC transition, and use it to demonstrate a Ramsey sequence with an Allan deviation

16 al system, we used behavioral and fMRI tasks to demonstrate a significant reduction in neural suppres

17 arge sample size and long follow-up required to demonstrate a significant treatment effect because of

18 glioma (LGG, grade II), as it was the first to demonstrate a survival benefit of adjuvant chemoradio

19 Our findings are among the first to demonstrate a transfer potential of experience-induce

20 To demonstrate a wider applicability as a screening and

21 Further work is needed to demonstrate accuracy when implemented as a point-of-c

22 We leverage machine learning to demonstrate accurate smartphone-based eye tracking wi

23 Failure to demonstrate ACM benefit should not diminish advances

24 A simple model was applied to demonstrate an analytical approach for evaluating the

25 l absorption-to characterize the exciton and to demonstrate an extremely narrow excitonic linewidth b

26 calculated alongside a large set of devices to demonstrate an intrinsic upper limit of D* as a funct

27 etal tissue grafts but has not been possible to demonstrate and study in toxin-based animal models.

28 IL-13 together with IL-4 failed to demonstrate any synergistic effect.

29 dified paper-based device has been developed to demonstrate application in low-cost detection of a fo

30 ), the authors took an outcome-wide approach to demonstrate associations between religious practices

31 lysis coupled to an extraction unit in order to demonstrate automated sample-to-data operation.

32 We proceed to demonstrate broad-based, two-plex, four-plex, and six

33 To demonstrate capabilities, the system was used to over

34 We employ this system in an in vivo model to demonstrate cell-type-specific requirements for a par

35 ees C) and CO(2) flow rates (3.3-3.7 mL/min) to demonstrate column stability and application of this

36 To demonstrate computational spectroscopy, we provide ou

37 ral dose of nicotinic acid using cardiac MRI to demonstrate contractile function and Phosphorus-31 ((

38 we employed a substrate competition strategy to demonstrate DapF (Ct) function in vivo in C. trachoma

39 Here we use specially engineered QDs to demonstrate devices that operate as both a light emit

40 hical structure of the visual motion pathway to demonstrate dissociation in the fMRI response magnitu

41 internal reflection fluorescence microscopy to demonstrate dynamic colocalization with TRIM proteins

42 o define the weight of evidence with respect to demonstrated effect mechanisms.

43 is in the peripheral skeleton but has failed to demonstrate efficacy in AS that is largely a spinal p

44 We leverage this capability to demonstrate EndoVIPER-seq (Endonuclease V inosine pre

45 )Fe(0.5)O(5+delta) (PBSCF) as a model system to demonstrate enhancing OER activity through the promot

46 T5 loss of function have allowed researchers to demonstrate essential roles for PRMT5 in mouse and hu

47 solid tumors treated with ICB, we are unable to demonstrate favorable response to ICB in patients wit

48 ctrometry (UPLC-MS/MS) as a reference method to demonstrate food analysis in real samples.

49 Moreover, "risk-taking" subjects were found to demonstrate greater phasic dopamine release than "ris

50 To demonstrate H. arabidopsidis sRNA (HpasRNA) functiona

51 Peanut-allergic patients appear to demonstrate higher absorption rate, the clinical sign

52 received intraarterial administration failed to demonstrate higher uptake by hepatic metastases than

53 ALS), FTIR and solid-state NMR spectroscopy) to demonstrate how a hierarchical design strategy for a

54 to detect and amplify low-amplitude signals, to demonstrate how a simple electrical circuit which use

55 community garden networks as a model system to demonstrate how biophysical and social features of ur

56 resonance imaging, and vocal tract modeling to demonstrate how biphonation is achieved by modulating

57 0) use optogenetics and biophysical modeling to demonstrate how cells respond to different oscillator

58 We also use our method to demonstrate how inputs can be used to control network

59 red free-ranging cheetahs (Acinonyx jubatus) to demonstrate how new insights into the socio-spatial o

60 ic stroke care provides a useful application to demonstrate how simulation modeling can be used to de

61 use a unique set of terrestrial experiments to demonstrate how soil management practises result in e

62 ate and unify multiple metabolic models, and to demonstrate how the fitness landscape of strategies b

63 lutionary game theory and dynamical networks to demonstrate how the specificity and sensitivity of th

64 emization on asteroidal parent bodies is key to demonstrating how amino acids evolved to be mostly le

65 to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes.

66 largest cohort study with extended follow-up to demonstrate impaired immune health in survivors of DL

67 Here, we first validated a new task to demonstrate impairments in cued turning behavior in r

68 To our knowledge, this is the first regimen to demonstrate improved antitumor activity against BMs i

69 of well-characterized quorum sensing systems to demonstrate inducibility of multi-strain communities.

70 To demonstrate its biomedical potential, we further indu

71 as two real omics meta-analysis applications to demonstrate its insightful biological findings.

72 provide several examples of the UHS process to demonstrate its potential utility and applications, i

73 To demonstrate its practical use, we applied this approa

74 We illustrate plasso using simulations to demonstrate its superior performance over existing me

75 nd limited prospective studies are available to demonstrate methods to integrate PC within routine he

76 -31 ((31) P) magnetic resonance spectroscopy to demonstrate myocardial energetics.

77 These data are the first, to our knowledge, to demonstrate new roles for macrophage TRPV4 in regulat

78 And, we will need to demonstrate not only data stability but also the usef

79 rology, and finance, we explore and are able to demonstrate our method's power and accuracy to recons

80 Together, these results are the first to demonstrate phosphoregulation of FFA4-L as well as th

81 in transfer in the bifunctional ROCOP system to demonstrate precise molecular-weight control, CTA fun

82 Purpose To demonstrate preclinical and first-in-human applicatio

83 c pressure has been performed in this system to demonstrate product separation and emulsifier and cat

84 One patient went on to demonstrate progressive ocular disease that was noted

85 To demonstrate proof of concept and estimate effect size

86 rcuits, for instance, have already been used to demonstrate prototype quantum processors comprising a

87 Therefore, we were able to demonstrate QDB method as the first immunoassay platf

88 ng applications, but none have been reported to demonstrate reduction potentials powerful enough to r

89 t of scattered light from nanoliter droplets to demonstrate reliable detection of the proliferation o

90 1) to protect highly vulnerable patients, 2) to demonstrate respect for persons, 3) to provide approp

91 on-photon quasiparticles, have been proposed to demonstrate scatter-free chiral propagation, but thei

92 Here we use field surveys to demonstrate seasonal mismatches in the exposure of ma

93 In this article, the purpose was to demonstrate secondary radiological findings of osteoi

94 pathogenesis and a luciferase reporter virus to demonstrate sera collected from SARS and COVID-19 pat

95 I error; and potential low statistical power to demonstrate significant between-group differences on

96 d the least benefit and in some cases failed to demonstrate significant weight gain despite nutrition

97 The imprinted surface was initially designed to demonstrate specific affinity toward a short peptide

98 -12 and BL21) with known sequence divergence to demonstrate strain-specific differences.

99 model mucin system, this is the first study to demonstrate strong interactions between vancomycin an

100 To demonstrate test efficacy with other sample matrices,

101 This framework was recently applied to demonstrate that "subtype" approaches, in which peopl

102 his clinical feasibility study was performed to demonstrate that (68)Ga-RGD PET/CT imaging can be use

103 ling theory and use global simulation models to demonstrate that (i) megabiota are more prone to exti

104 e these targets, tool molecules are required to demonstrate that a ligand can have a disease-modifyin

105 utilize pluripotent stem cell models to demonstrate that a primate lncRNA, BANCR, is primaril

106 ine model of C. difficile disease recurrence to demonstrate that an initial infection induced a serum

107 The aim was to demonstrate that antibodies from patients with anti-N

108 rting computational modeling and simulation, to demonstrate that Arabidopsis (Arabidopsis thaliana) C

109 port measurements and hormone quantification to demonstrate that Arabidopsis and Medicago CEP (C-TERM

110 r structural imaging procedures and analyses to demonstrate that aspiration lesion of central orbitof

111 Our objective was to demonstrate that asymptomatic nasopharyngeal carriage

112 in E. coli These results serve as a paradigm to demonstrate that bacterial adaptation to long-term nu

113 The authors fail to demonstrate that bees can access the concealed nectar

114 continuous time implementation of the model to demonstrate that Cdc14 Early Anaphase Release (FEAR)

115 m data capturing both desktop and mobile use to demonstrate that coexposure to diverse news is on the

116 aset which emulates human samples and use it to demonstrate that combining multiple spatial statistic

117 nt a retroactive assessment of entanglements to demonstrate that cooperation of fishers, resource man

118 We aimed to demonstrate that Cu-ATSM signal is dependent on cellu

119 grid-scale estimates of N inputs and outputs to demonstrate that current N removal by US wetlands (ab

120 st of our knowledge, this is the first study to demonstrate that diabetes activates BMMO HuR expressi

121 pstream regulator, and histological analyses to demonstrate that DX314 can potentiate the effects of

122 the model organism Dictyostelium discoideum to demonstrate that Dync1li1 is an essential gene while

123 CANCE STATEMENT This study will be the first to demonstrate that enhanced neurogenesis by overexpress

124 combined with molecular dynamics simulations to demonstrate that fivefold twinning occurs through rep

125 Finally, to demonstrate that Hh levels are the cause of the plast

126 et digital polymerase chain reaction (ddPCR) to demonstrate that human DNA levels, a stable molecular

127 in brainstem slices from mice of either sex to demonstrate that in addition to excitatory glutamater

128 ing probe microscopy and molecular modelling to demonstrate that inhibitor pairs, whose constituents

129 vitro reconstituted yeast translation system to demonstrate that inhibitory codon pairs slow elongati

130 Overall, this is the first report to demonstrate that INT131 could be a potential candidat

131 Here, we present a unique case to demonstrate that interchain excitation energy migrati

132 To demonstrate that leakage did not occur, we applied de

133 mbine genetic and pharmacological approaches to demonstrate that MMUT deficiency induces metabolic an

134 colleagues perform in vivo metabolic tracing to demonstrate that mouse pancreatic ductal adenocarcino

135 on of mechanistic target of rapamycin (mTOR) to demonstrate that mTOR regulates expression of specifi

136 etic approaches and single-nuclei sequencing to demonstrate that muscle-derived Pvf1 signals to the D

137 Here, we use live imaging to demonstrate that NuMA plays a spindle-independent rol

138 underweight subgroups, this study was unable to demonstrate that nutritional status modified the effe

139 , we utilize the P301S tauopathy mouse model to demonstrate that pathological tau can exclude LSD1 fr

140 sually large size of Arabidopsis peroxisomes to demonstrate that peroxisomes have extensive internal

141 nstituted Saccharomyces cerevisiae replisome to demonstrate that Pif1 enables the replisome to bypass

142 Moreover, we use genome engineering to demonstrate that precise mutation of hth 3' UTR sites

143 e recently used passive joint angle matching to demonstrate that proprioception of the knee joint is

144 se of a multivariate pattern analysis (MVPA) to demonstrate that stimulation of three DBS targets (ST

145 -HT(3A)) serotonin receptor for 15 to 20 mus to demonstrate that such timescales are critical to obse

146 We then used sequence and domain analysis to demonstrate that tandem LIM domains contribute additi

147 ropose five criteria that all need to be met to demonstrate that temperature-mediated trophic asynchr

148 ring reconstructions of summer soil moisture to demonstrate that the 2000-2018 SWNA drought was the s

149 bination of biochemical and genetic analyses to demonstrate that the ability of the nascent subunit t

150 uclear magnetic resonance (NMR) spectroscopy to demonstrate that the apparent first-cycle capacity lo

151 of lobe formation in these cells allowed us to demonstrate that the auxin response gradient forms wi

152 Network proximity analysis was used to demonstrate that the calcificasome overlapped signifi

153 Here, we use simulations to demonstrate that the coverage probabilities are over-

154 ometry-based proteomic and phenotypic assays to demonstrate that the expression of active noncanonica

155 ethod simulation and experimental validation to demonstrate that the fiber patterning strategy is eff

156 Evidence has accumulated to demonstrate that the intestinal microbiota enhances m

157 eed interference contrast microscopy is used to demonstrate that the irregular pattern of fibers in t

158 , proteomic, and structural biology approach to demonstrate that the lethal Australian funnel-web spi

159 chine learning methods are employed together to demonstrate that the liquid adjacent to solid-liquid

160 Here, we use cryo-electron tomography to demonstrate that the microtubule lumen can be occupie

161 y decomposition analysis (EDA), we were able to demonstrate that the Pauli repulsion term increases m

162 es of the prepared heterocycles were studied to demonstrate that the prepared compounds are attractiv

163 uroursodeoxycholic acid treatments were used to demonstrate that the protein folding capacity signifi

164 step in testing this hypothesis, we set out to demonstrate that the tricuspid valve maladapts in dis

165 g an acute stressor and use machine learning to demonstrate that these networks can specifically pred

166 ty tests with cells were finally carried out to demonstrate that this approach may represent a promis

167 talar joint centre of rotation, which allows to demonstrate that this centre of rotation is located i

168 To demonstrate that this deposition scheme preserves the

169 ntaining a central benzothiadiazole(10) unit to demonstrate that this strategy can be used to create

170 in an intestinal transplant patient, we aim to demonstrate that tolerance is possible in a field tha

171 imulated and real-world combination datasets to demonstrate that traditional index methods are unstab

172 -competent and incompetent cancer cell pairs to demonstrate that treatment with alpha-ketoglutarate (

173 lysis, biochemistry and pathogenicity assays to demonstrate that VdAtf1 governs pathogenesis via the

174 ral orthogonal structure-interaction methods to demonstrate that XIST RNA-protein complex folds into

175 tem in Nicotiana benthamiana that allowed us to demonstrate that ZAR1 function is conserved from the

176 iple-negative breast cancer (TNBC) subtypes, to demonstrate that ZEB1 represses POLQ expression.

177 me series data obtained from humans and mice to demonstrate that, despite their inherent complexity,

178 We use analogue models of normal faults to demonstrate that, without the influence of pre-existi

179 er Analysis of Whole Genomes (PCAWG) project to demonstrate that-in addition to the dichotomy of high

180 ss spectrometer, and anode in the laboratory to demonstrate the 3DI prototype's performance.

181 To demonstrate the accessibility and porosity of the mac

182 This is the first study to demonstrate the applicability of an untargeted, activ

183 To demonstrate the applicability of DRAM across metaboli

184 To demonstrate the applicability of the developed EW-CRD

185 everal grape varieties were studied in order to demonstrate the applicability of the method to the an

186 To demonstrate the benefits of our model, we compared it

187 To demonstrate the breadth of applicability of this tech

188 To demonstrate the capabilities of DCyFIR, we engineered

189 on of 4-aminothiophenol as two model systems to demonstrate the capabilities of these bifunctional na

190 fferent polarization states of the pump beam to demonstrate the capability of controlling the intensi

191 To demonstrate the capability of this bioaerosol sensing

192 ow concentration of nanoparticles allowed us to demonstrate the capability of TOF-SIMS to spatially r

193 eliminary mechanistic studies were performed to demonstrate the crucial role of boron catalyst for th

194 In clinical trials designed to demonstrate the CVD safety of SGLT2 inhibitors in typ

195 y used high-resolution X-ray crystallography to demonstrate the detailed nature of the interactions b

196 ar geometry followed by in situ spectroscopy to demonstrate the device functioning and (2) by carryin

197 nalization processes have also been explored to demonstrate the divergent synthetic utility of the un

198 ated their cost per year of functional life, to demonstrate the economic and public health importance

199 ermal cellular thermal shift assays (CETSAs) to demonstrate the effective cellular target engagement

200 array of simulated and experimental datasets to demonstrate the effectiveness of GPseudoClust in a ra

201 system, 10.9 +/- 1.0 nm Au NPs were analyzed to demonstrate the effects of increasing ion transmissio

202 We perform safety testing to demonstrate the efficacy of our HUDSON protocol in he

203 To demonstrate the efficacy of our technique, we apply t

204 this large descriptive study was not powered to demonstrate the efficacy of these prophylactic measur

205 To demonstrate the efficiency as a POC cancer diagnostic

206 vice for the first time using this precursor to demonstrate the electronic functionality of the mater

207 w and reported quantum-chemical calculations to demonstrate the excited state leading to the formatio

208 topotactic intercalation chemistry was used to demonstrate the feasibility of bromine intercalation

209 in mono and disaccharides has been developed to demonstrate the feasibility of detecting undeclared a

210 n Switzerland, which is used as a case study to demonstrate the feasibility of our approach, it is po

211 ugh micro-patterned triangular masks is used to demonstrate the feasibility of scalable formation of

212 To demonstrate the feasibility of this approach, we have

213 To demonstrate the fitness for use and robustness of thi

214 To demonstrate the framework introduced, we investigate

215 Two data sets are used to demonstrate the functionality of the process.

216 scattering and spectroscopy methods are used to demonstrate the generality and sensitivity of (19)F s

217 To demonstrate the generality, this strategy is also use

218 n platforms and affinity depletion platforms to demonstrate the impact of HCP-mAb interaction on lipa

219 Our study is the first to demonstrate the importance of energy compensation to

220 different estimation approaches for SSFs and to demonstrate the importance of including individual-sp

221 ics of living systems, giving a few examples to demonstrate the importance of nonequilibrium thermody

222 ns were then evaluated as immunogens in mice to demonstrate the induction of functionally active poly

223 (DKK3), was successfully used as a biomarker to demonstrate the inhibition of HtrA1 activity in patie

224 nd ultraviolet-visible spectrometry was used to demonstrate the link between source water characteris

225 ed sediment sample (Roskilde Fjord, Denmark) to demonstrate the method efficiency.

226 As a case study to demonstrate the method, random forest and support vec

227 To demonstrate the need for strain validation by WGS, we

228 l bonds as electron reservoirs is introduced to demonstrate the new concept of "structronics" (a neol

229 To demonstrate the operation of the on-line SDE-GC/MS sy

230 s developed using the closure of the algebra to demonstrate the parallel information processing at th

231 y neural sampling by retinal ganglion cells, to demonstrate the perceptual effects of blur, aliasing,

232 To demonstrate the performance of the carrier-modulated

233 examples using empirical and simulated data to demonstrate the performance of the package kernel iso

234 To demonstrate the potential applicability of this new c

235 This is the first study to demonstrate the potential clinical utility of blood a

236 To demonstrate the potential for clinical application, f

237 This study is the first to demonstrate the potential of Cu isotopes in bivalves

238 Overall, the present work appears to demonstrate the potential of multiscale modeling in e

239 To demonstrate the potential of these methods, a 4D para

240 To demonstrate the potential of this technology, the ele

241 To demonstrate the power of VirtualFlow, we screened mor

242 activation in aqueous medium in high yields to demonstrate the practicability of this present method

243 To demonstrate the prediction power of our approach, we

244 re, we adapt single molecule FISH techniques to demonstrate the presence and activity of mRNAs at the

245 ts, rate measurements and molecular analyses to demonstrate the presence of a cryptic methane cycle i

246 To demonstrate the presence of these anti-inflammatory,

247 This study sought to demonstrate the prognostic value of LV GLS over LVEF

248 Previous studies served to demonstrate the proof of concept for the use of quant

249 To demonstrate the relevance and validity of the new tes

250 To demonstrate the reported focusing lens can be a usefu

251 To demonstrate the resulting UQ capabilities, we analyze

252 Herein, we review recent developments to demonstrate the scope and limitations of this interes

253 alloy NCs and NPs are used as a model system to demonstrate the semiconductive-to-metallic conductivi

254 To demonstrate the sensor concept experimentally, we fab

255 To demonstrate the sensor's specificity, tests against S

256 first principles-based approach is discussed to demonstrate the significance of this sensing framewor

257 acking experiment of filaments and membranes to demonstrate the simulation ability of deformable stru

258 t microbiome data applications are conducted to demonstrate the superior performance of our empirical

259 d sulfur-triazole exchange (SuTEx) chemistry to demonstrate the triazole as an effective LG for activ

260 , these studies are among the first attempts to demonstrate the unrevealed potential of a confined sc

261 a set that included artificial data in order to demonstrate the use of the formulas and calculate the

262 myces cerevisiae was adopted as a case study to demonstrate the usefulness of the proposed approach i

263 To demonstrate the usefulness of this new method to real

264 To demonstrate the utility of ASCOT, we identify novel c

265 To demonstrate the utility of Binner and to evaluate its

266 w fever, West Nile, and chikungunya viruses, to demonstrate the utility of genomic epidemiology to su

267 To demonstrate the utility of our approach, we screened

268 To demonstrate the utility of our platform, we have synt

269 To demonstrate the utility of the EC-enriched monolayer

270 Further transformations to demonstrate the utility of these scaffolds were also

271 To demonstrate the utility of this fiber, it is machine-

272 wo different therapeutic windows, as a means to demonstrate the utility of this novel longitudinal im

273 To demonstrate the utility of this synthetic route to pr

274 -2 and three mutant forms (A16G, K11A, L32A) to demonstrate the utility of variable-temperature (vT)

275 uce several well-known associations with PD, to demonstrate the validity of a PRS and to demonstrate

276 m falciparum, Hepatitis C virus and T-cells) to demonstrate the value of compiling this data.

277 To demonstrate the value of this framework, we analyze R

278 Herein, we use these probes to demonstrate the visible light mediated bidirectional

279 balance in temporal and multilayer networks to demonstrates the generalizability of our approach.

280 In addition to demonstrating the potential benefits associated with

281 to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes.

282 ate eight out of 15 of the identified miRNAs to demonstrate their role in deficit moisture stress tol

283 entative reactions will be further discussed to demonstrate their structure-property relationships.

284 significant manual interventions or have yet to demonstrate their utility in large datasets.

285 ogy in colorectal surgery, there is a burden to demonstrate these benefits.

286 To demonstrate this approach, we collected a multidimens

287 To demonstrate this array's use in light detection and r

288 To demonstrate this concept, we prepared n-Si/Au nanopar

289 clinical management of hypercholesterolemia, to demonstrate this concept.

290 To demonstrate this sensor for practical applications, t

291 To demonstrate this utility, we fused TTR to the C termi

292 To demonstrate this we first modified the designed helic

293 To demonstrate this, we use dual-trap optical tweezers,

294 By pursuing the diagnostic protocol to demonstrate tolerance to other nuts, participants wer

295 ith a high concentration of oxygen vacancies to demonstrate two oxide/poly(ethylene oxide) (PEO)-base

296 larger error of 24.2% and hence is included to demonstrate versatility.

297 SARS-CoV-2 spike pseudovirus and live virus to demonstrate viral tropism for choroid plexus epitheli

298 Mean error (ME) was also calculated to demonstrate whether a formula tended toward more myop

299 Studies in animal models are needed to demonstrate whether neurological syndromes are direct

300 he cysteine mutation to the native receptor, to demonstrate with high pharmacological specificity tha